Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01083849 · BASELINE

Baseline characteristics

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice · Source last updated 2014-12-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      121
    2. group Id
      BG001
      value
      638
    3. group Id
      BG002
      value
      759
    units
    Participants
groups
  1. description
    Participants with chronic kidney disease and a diagnosis of secondary hyperparathyroidism, and who were not yet on dialysis received paricalcitol injection or capsules, on an on-label basis in an everyday setting. Participants were observed for 12 months.
    id
    BG000
    title
    Paricalcitol Pre-dialysis Group
  2. description
    Participants with chronic kidney disease and a diagnosis of secondary hyperparathyroidism, and on dialysis received paricalcitol injection or capsules, on an on-label basis in an everyday setting. Participants were observed for 12 months.
    id
    BG001
    title
    Paricalcitol Dialysis Group
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          13.9
          value
          64.2
        2. group Id
          BG001
          spread
          14.9
          value
          62.5
        3. group Id
          BG002
          spread
          14.8
          value
          62.8
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          47
        2. group Id
          BG001
          value
          291
        3. group Id
          BG002
          value
          338
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          74
        2. group Id
          BG001
          value
          347
        3. group Id
          BG002
          value
          421
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          36.0
          value
          39.3
        2. group Id
          BG001
          spread
          61.1
          value
          71.2
        3. group Id
          BG002
          spread
          59.6
          value
          67.5
    description
    Duration of Chronic Kidney Disease until the start of the study
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Duration of Chronic Kidney Disease
    unit Of Measure
    months
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          20.6
          value
          17.7
        2. group Id
          BG001
          spread
          36.6
          value
          43.9
        3. group Id
          BG002
          spread
          35.8
          value
          39.5
    description
    Duration of Secondary Hyperparathyroidism until the start of the study
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Duration of Secondary Hyperparathyroidism
    unit Of Measure
    months
population Description
A total of 761 participants were enrolled in the study, however 2 participants lacked information necessary for assignment to one of the analysis groups. Hence, analysis was conducted with 759 participants.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      121
    2. group Id
      BG001
      value
      638
    3. group Id
      BG002
      value
      759
    units
    Participants
groups
  1. description
    Participants with chronic kidney disease and a diagnosis of secondary hyperparathyroidism, and who were not yet on dialysis received paricalcitol injection or capsules, on an on-label basis in an everyday setting. Participants were observed for 12 months.
    id
    BG000
    title
    Paricalcitol Pre-dialysis Group
  2. description
    Participants with chronic kidney disease and a diagnosis of secondary hyperparathyroidism, and on dialysis received paricalcitol injection or capsules, on an on-label basis in an everyday setting. Participants were observed for 12 months.
    id
    BG001
    title
    Paricalcitol Dialysis Group
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          13.9
          value
          64.2
        2. group Id
          BG001
          spread
          14.9
          value
          62.5
        3. group Id
          BG002
          spread
          14.8
          value
          62.8
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          47
        2. group Id
          BG001
          value
          291
        3. group Id
          BG002
          value
          338
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          74
        2. group Id
          BG001
          value
          347
        3. group Id
          BG002
          value
          421
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          36.0
          value
          39.3
        2. group Id
          BG001
          spread
          61.1
          value
          71.2
        3. group Id
          BG002
          spread
          59.6
          value
          67.5
    description
    Duration of Chronic Kidney Disease until the start of the study
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Duration of Chronic Kidney Disease
    unit Of Measure
    months
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          20.6
          value
          17.7
        2. group Id
          BG001
          spread
          36.6
          value
          43.9
        3. group Id
          BG002
          spread
          35.8
          value
          39.5
    description
    Duration of Secondary Hyperparathyroidism until the start of the study
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Duration of Secondary Hyperparathyroidism
    unit Of Measure
    months
population Description
A total of 761 participants were enrolled in the study, however 2 participants lacked information necessary for assignment to one of the analysis groups. Hence, analysis was conducted with 759 participants.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice